About US
Contact us
-
Mylan's Tecfidera generic launch jolts Biogen, putting billions at stakeDespite Biogen's intense effort to defend its big-selling multiple sclerosis drug Tecfidera, Mylan has cleared several hurdles to launch a copycat, and now it's doing just that. After an early FDAapp2020/8/18
-
Takeda to sell Japan consumer health unit to Blackstone for $2B-plus: reportsThe final—and the biggest—piece of Takeda’s $10 billion divestment plan could be wrapped up soon. The Japanese pharma isin the final stage of talksto sell its domestic consumer health business to U.S2020/8/18
-
New York wraps Allergan and Teva into ongoing opioid abuse probe with new civil chargesNew York Governor Andrew Cuomo may have been preoccupied with getting the COVID-19 pandemic under control in his state over the past few months, but that hasn’t stopped him from going after the opioi2020/8/17
-
Japanese CMO Bushu plugs $100M into broad expansion plans for 'Asia hub'Japanese contract manufacturer Bushu Pharmaceuticals has held a spot as the top company in its field following a big buyout six years ago. Now, with plans to become an "Asia hub" for pharmaceutical i2020/8/17
-
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analystWhen longtime Evercore ISI pharma analyst Josh Schimmer realized that investors were struggling to place valuations on the leading COVID-19 vaccine developers, he pulled out the proverbial envelope,2020/8/14
-
Belgium's Ajinomoto doubles Indian small-molecule manufacturing cap with new facilityBelgian CDMO Ajinomoto Bio-Pharma Services has been on a run in recent of years expanding its operations around the world. That was the goal of an Indian joint venture buyout back in 2018—and nowAjin2020/8/14
-
Bristol Myers Squibb takes on racial inequality with $300M pledge to up diversity, improve healthcare accessThe recent death of George Floyd hasset off a broad discussion around racism and the different forms of inequalitypeople of color experience in the U.S. One of the disparities lies in healthcare, and2020/8/13
-
After nearly $1B in research funding, Moderna takes $1.5B coronavirus vaccine order from U.S.Through its COVID-19 vaccine partnership with the U.S. government, Moderna picked up nearly $1 billion in research aid. Now, it's joining a list of other companies to take a supplyorder from the fede2020/8/13
-
Mesoblast faces FDA pushback over cell therapy manufacturing, clinical data: documentsThe FDA in recent years has been tough on cell and gene therapy makers, particularly when its comes to approving thelabor-intensive and complicated manufacturing process. The agency now has its eyes2020/8/12
-
AstraZeneca bumps up vaccine deal with Brazil to $360M with more doses, licensing rightsIn an effort to supercharge distribution of its vaccine hopeful, British drugmaker AstraZeneca has spanned the globe to ink a slew of national supply deals. Now, after striking a more limited pact in2020/8/12